Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice
β Scribed by Yuko Nakanishi; Koichi Tsuneyama; Kazuhiro Nomoto; Makoto Fujimoto; Thucydides L. Salunga; Takahiko Nakajima; Shigeharu Miwa; Yoshihiro Murai; Shinichi Hayashi; Ichiro Kato; Koichi Hiraga; Daniel K. Hsu; Fu-Tong Liu; Yasuo Takano
- Book ID
- 118088018
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 827 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi
Galectins are a family of β€-galactoside-binding animal lectins. In particular, a widely studied member galectin-3, previously designated as βBP, CBP35, Mac-2, L-29 and L-34, has been associated with assorted processes such as cell growth, tumor transformation and metastasis. Galectin-3 is expressed
LKB1, originally considered a tumor suppressor, plays an important role in hepatocyte proliferation and liver regeneration. Mice lacking the methionine adenosyltransferase (MAT) gene MAT1A exhibit a chronic reduction in hepatic S-adenosylmethionine (SAMe) levels, basal activation of LKB1, and sponta
## Abstract Metallothionein (MT) is a highβaffinity metal binding protein thought to mitigate the toxicity of various metals. Cisplatin is a widely used cancer chemotherapeutic that is a rodent carcinogen and may have carcinogenic potential in humans. MT seems to reduce cisplatin toxicity by bindin